Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 125

1.

A nationwide survey of past hepatitis A infections among Canadian adults.

Scheifele DW, De Serres G, Gilca V, Duval B, Milner R, Ho M, Ochnio JJ.

Vaccine. 2010 Jul 19;28(32):5174-8. doi: 10.1016/j.vaccine.2010.05.076. Epub 2010 Jun 15.

PMID:
20558251
2.

Nationwide canadian study of hepatitis a antibody prevalence among children eight to thirteen years old.

Duval B, De Serres G, Ochnio J, Scheifele D, Gîlca V.

Pediatr Infect Dis J. 2005 Jun;24(6):514-9.

PMID:
15933561
3.

Participant-collected, mail-delivered oral fluid specimens can replace traditional serosurveys: a demonstration-of-feasibility survey of hepatitis A virus-specific antibodies in adults.

Ochnio JJ, Scheifele DW, Marion SA, Bigham M, Patrick DM, Ho M, Mozel M.

Can J Public Health. 2007 Jan-Feb;98(1):37-40.

PMID:
17278676
4.
6.

Age related seroprevalence of antibodies to hepatitis A virus in Hyderabad, India.

Joshi N, Yr NK, Kumar A.

Trop Gastroenterol. 2000 Apr-Jun;21(2):63-5.

PMID:
10881625
7.
8.

Hepatitis A vaccination coverage among adults 18-49 years traveling to a country of high or intermediate endemicity, United States.

Lu PJ, Byrd KK, Murphy TV.

Vaccine. 2013 May 1;31(19):2348-57. doi: 10.1016/j.vaccine.2013.03.011. Epub 2013 Mar 21.

PMID:
23523408
10.

Hepatitis A seroprevalence and risk factors among day-care educators.

Muecke CJ, Béliveau C, Rahme E, Soto JC, Gyorkos TW.

Clin Invest Med. 2004 Oct;27(5):259-64.

PMID:
15559862
11.

Epidemiology of hepatitis A and hepatitis E infection and their determinants in adult Chinese community in Hong Kong.

Wong KH, Liu YM, Ng PS, Young BW, Lee SS.

J Med Virol. 2004 Apr;72(4):538-44.

PMID:
14981755
12.
13.

Prevalence of hepatitis A virus risk factors in a very low endemic country, Switzerland.

Mohler-Kuo M, Steffen R, Bopp M, Jacobs RJ, Mutsch M.

Vaccine. 2007 Dec 17;25(52):8718-25. Epub 2007 Nov 5.

PMID:
18061318
14.

A prevalence study of hepatitis A virus infection in a migrant community: Is hepatitis A vaccine indicated?

Dentinger CM, Heinrich NL, Bell BP, Fox LM, Katz DJ, Culver DH, Shapiro CN.

J Pediatr. 2001 May;138(5):705-9.

PMID:
11343047
15.

Age-Specific Anti-Hepatitis A Virus Seroepidemiology in Italian Travelers: Indications for Anti-Hepatitis A Vaccination.

Castelli F, Carosi G, Tebaldi A, Pizzocolo G, Pisani S, Rossitto F, Boffelli L, Crevatin D, Pettoello R, Fausti G, Messino C, Brunelli M, Costa P, Ronca E.

J Travel Med. 1996 Dec 1;3(4):214-218.

16.

Could oral fluid be used to evaluate anti-hepatitis A virus status in individuals living in difficult-to-access areas?

Tourinho RS, de Almeida AJ, Amado LA, Villar LM, Castro AR, de Paula VS.

Vaccine. 2012 Oct 5;30(45):6421-6. doi: 10.1016/j.vaccine.2012.08.015. Epub 2012 Aug 19.

17.

Viral hepatitis in Bucharest.

Paquet C, Babes VT, Drucker J, Sénémaud B, Dobrescu A.

Bull World Health Organ. 1993;71(6):781-6.

18.

Incidence of HAV and HBV infections and vaccination rates in patients with autoimmune liver diseases.

Wörns MA, Teufel A, Kanzler S, Shrestha A, Victor A, Otto G, Lohse AW, Galle PR, Höhler T.

Am J Gastroenterol. 2008 Jan;103(1):138-46. Epub 2007 Oct 26.

PMID:
17970833
19.
20.

Hepatitis A infection: a seroepidemiological study in young adults in North-East Italy.

Moschen ME, Floreani A, Zamparo E, Baldo V, Majori S, Gasparini V, Trivello R.

Eur J Epidemiol. 1997 Dec;13(8):875-8.

PMID:
9476815

Supplemental Content

Support Center